Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Thaçi, Diamant
  • Puig, Lluís
  • Reich, Kristian
  • Tsai, Tsen-Fang
  • Tyring, Stephen
  • Kingo, Külli
  • Ziv, Michael
  • Pinter, Andreas
  • Vender, Ronald
  • Lacombe, Aude
  • Xia, Summer
  • Bhosekar, Vaishali
  • Gilloteau, Isabelle
  • Guana, Adriana
  • Blauvelt, Andrew

publication date

  • December 2019